Dell Medical School

Texas Biologics & HTRI Translational Research Teams

Texas Biologics and HTRI have partnered to accelerate translational research projects that aim to uncover mechanisms of disease to target for development of therapeutics or identify new therapeutic approaches or diagnostic tools. Please join us in congratulating the supported teams listed below.

2023

Annie Feagins, MD, Marissa Burgermaster, PhD, Chris Jolly, PhD, Kelly Reveles, PhD, PharmD: Feasibility of beta hydroxybutyrate supplementation to reduce inflammation in patients with Inflammatory Bowel Disease

Lorie Harper, MD, Beth Widen, PhD RD, Jaimie Davis, PhD RD, Molly Bray, PhD, Brian Hobbs, PhD: Early biomarkers of excessive gestational weight gain

Pooja Varshney, MD, Ed Satterwhite, PhD: IgE Repertoire Analysis in Pediatric Food Allergy


Funding Acknowledgement

Please acknowledge funding for any published papers (deposited in PubMed Central) and poster presentations resulting from this support in the following way:

“This project was funded [fully or in part] by the University of Texas at Austin Texas Biologics and Dell Medical School’s Health Transformation Research Institute (HTRI).”